The Uttar Pradesh government on Sunday banned the coldrif cough syrup manufactured by Shreesan Pharmaceutical following reports of severe side effects, resulting in the death of 14 children in Madhya Pradesh.

The state’s Assistant Commissioner of Drug Administration has issued instructions to all drug inspectors to collect samples of the cough syrup manufactured by Shreesan Pharmaceutical Chhindwarafrom both government and private institutions across Uttar Pradesh.

These samples will be sent to a laboratory in Lucknow for testing.

The order also prohibits the import and export of the cough syrup in government and private institutions until further notice. Authorities have emphasised strict compliance with the instructions to ensure public safety.

The officials said that the action is b

See Full Page